within Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L01X_OtherAntineoplasticAgents.L01XX80_Imetelstat;

model Imetelstat
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C(
    weight = 70,
    F = 1,
    Cl = 3.713888888888889e-06,
    adminDuration = 600,
    adminMass = 9.4 / 1000000,
    adminCount = 1,
    Vd = 0.0125,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    Vdp = 0.0114,
    k12 = 5.930555555555556e-06,
    k21 = 5.930555555555556e-06);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Imetelstat</td></tr><tr><td>ATC code:</td><td>L01XX80</td></tr><td>route:</td><td>intravenous</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>9.4</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>12.5</td><td>L</td></tr>
    <tr><td>clearance:</td><td>0.191</td><td>L/h/kg</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Imetelstat is a first-in-class, telomerase inhibitor oligonucleotide used primarily in the treatment of hematologic malignancies such as myelofibrosis and myelodysplastic syndromes. It is administered intravenously and is currently under investigation and approved for specific indications in some regions.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters based on adult patients with intermediate-2 or high-risk myelofibrosis, administered imetelstat via intravenous infusion. Parameters reflect average population PK from phase 2 clinical data.</p><h4>References</h4><ol><li><p>González-Sales, M, et al., &amp; Morcos, PN (2024). Population pharmacokinetics of imetelstat, a first-in-class oligonucleotide telomerase inhibitor. <i>CPT: pharmacometrics &amp; systems pharmacology</i> 13(7) 1264–1277. DOI:<a href=\"https://doi.org/10.1002/psp4.13160\">10.1002/psp4.13160</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/38771074/\">https://pubmed.ncbi.nlm.nih.gov/38771074</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.L.L01XX80 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Imetelstat;
